These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 31634480)

  • 1. A novel differential scanning fluorimetry analysis of a humanized anti-cocaine mAb and its ligand binding characteristics.
    Kirley TL; Norman AB; Wetzel HN
    J Immunol Methods; 2020 Jan; 476():112676. PubMed ID: 31634480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cocaine binding to the Fab fragment of a humanized anti-cocaine mAb quantitated by dye absorption and fluorescence spectroscopy.
    Kirley TL; Norman AB
    J Immunol Methods; 2021 Sep; 496():113103. PubMed ID: 34298065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical evaluation of fluorescent dyes to evaluate the stability and ligand binding properties of an anti-cocaine mAb, h2E2.
    Kirley TL; Norman AB
    J Immunol Methods; 2022 Sep; 508():113323. PubMed ID: 35843267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine nitration of a humanized anti-cocaine mAb differentially affects ligand binding of cocaine and its metabolites.
    Kirley TL; Greis KD; Norman AB
    Biochem Biophys Rep; 2022 Jul; 30():101278. PubMed ID: 35600901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand binding to a humanized anti-cocaine mAb measured by dye absorption spectroscopy.
    Kirley TL; Norman AB
    Biochem Biophys Res Commun; 2021 Jan; 535():93-98. PubMed ID: 33348081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment.
    Kirley TL; Norman AB
    Hum Vaccin Immunother; 2015; 11(2):458-67. PubMed ID: 25692880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ligand binding to a humanized anti-cocaine mAb detected by non-reducing SDS-PAGE.
    Kirley TL; Norman AB
    Biochem Biophys Rep; 2020 Sep; 23():100795. PubMed ID: 32817883
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-domain unfolding of the Fab fragment of a humanized anti-cocaine mAb characterized by non-reducing SDS-PAGE.
    Kirley TL; Norman AB
    Biochem Biophys Res Commun; 2020 Dec; 533(3):580-585. PubMed ID: 32988582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of free and liganded forms of the Fab fragment of a high-affinity anti-cocaine antibody, h2E2.
    Tan K; Zhou M; Ahrendt AJ; Duke NEC; Tabaja N; Ball WJ; Kirley TL; Norman AB; Joachimiak A; Schiffer M; Wilton R; Pokkuluri PR
    Acta Crystallogr F Struct Biol Commun; 2019 Nov; 75(Pt 11):697-706. PubMed ID: 31702583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidation of specific tryptophan residues inhibits high-affinity binding of cocaine and its metabolites to a humanized anticocaine mAb.
    Kirley TL; Norman AB; Greis KD
    J Biol Chem; 2022 Mar; 298(3):101689. PubMed ID: 35143837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isothermal titration calorimetry determination of thermodynamics of binding of cocaine and its metabolites to humanized h2E2 anti-cocaine mAb.
    Kirley TL; Norman AB
    Biochem Biophys Rep; 2022 Dec; 32():101354. PubMed ID: 36186732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous High-Throughput Conformational and Colloidal Stability Screening Using a Fluorescent Molecular Rotor Dye, 4-(4-(Dimethylamino)styryl)-N-Methylpyridinium Iodide (DASPMI).
    Wong JJ; Wright SK; Ghozalli I; Mehra R; Furuya K; Katayama DS
    J Biomol Screen; 2016 Sep; 21(8):842-50. PubMed ID: 27138878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel partial reduction of the humanized anti-cocaine mAb h2E2 for selective cysteine labeling.
    Kirley TL; Norman AB
    Biochem Biophys Res Commun; 2024 Jan; 692():149362. PubMed ID: 38071891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of a humanized recombinant anti-cocaine monoclonal antibody on the disposition of cocaethylene in mice.
    Wetzel HN; Tabet MR; Ball WJ; Norman AB
    Int Immunopharmacol; 2014 Dec; 23(2):387-90. PubMed ID: 25445957
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Differential Scanning Fluorimetry (DSF) to Detect Ligand Binding with Purified Protein.
    Li X; Zhang C
    Methods Mol Biol; 2021; 2213():183-186. PubMed ID: 33270203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization and optimization of fluorescein isothiocyanate labeling of humanized h2E2 anti-cocaine mAb.
    Kirley TL; Norman AB
    Biochem Biophys Rep; 2023 Sep; 35():101520. PubMed ID: 37554426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential scanning calorimetry and fluorimetry measurements of monoclonal antibodies and reference proteins: Effect of scanning rate and dye selection.
    Lang BE; Cole KD
    Biotechnol Prog; 2017 May; 33(3):677-686. PubMed ID: 28371560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DSF method optimization and its application in predicting protein thermal aggregation kinetics.
    Shi S; Semple A; Cheung J; Shameem M
    J Pharm Sci; 2013 Aug; 102(8):2471-83. PubMed ID: 23754479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput screening of formulations to optimize the thermal stability of a therapeutic monoclonal antibody.
    Niedziela-Majka A; Kan E; Weissburg P; Mehra U; Sellers S; Sakowicz R
    J Biomol Screen; 2015 Apr; 20(4):552-9. PubMed ID: 25385011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput melting-temperature analysis of a monoclonal antibody by differential scanning fluorimetry in the presence of surfactants.
    Menzen T; Friess W
    J Pharm Sci; 2013 Feb; 102(2):415-28. PubMed ID: 23212746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.